ANNA GARDNER: Open Payments
NPI 1265008312 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 50 payments from 18 companies in 2025. Trend: 2023 $126 · 2024 $389 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 1 | $229 |
| Otsuka America Pharmaceutical, Inc. | 16 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Solventum Corporation | 1 | $36 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $27 |
Products named: Zunveyl, REXULTI, Kerendia, CAPLYTA, FARXIGA, TRELEGY ELLIPTA, UBRELVY, PREVENA.
Industry payments across AL — which companies pay providers there.
